The biopsy is a minimally invasive surgical process performed to remove the tissue from the body for the determination of presence or extent of diseases such as cancer and inflammatory conditions. Generally, the biopsy is carried by radiologists, surgeons, and interventional cardiologists to confirm the presence of disease. A biopsy can be carried for the majority of organs in the body with the aid of specific biopsy devices. The various types of biopsy devices include skin biopsy, shave biopsy, fine needle aspiration, excision and incision biopsy, and vacuum-assisted biopsy among others. A sample of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/global-biopsy-devices-market/#ulp-4H8Z4LpNMLEuOnnx
Biopsy devices market is segmented on the basis of device type, application, imaging technologies, and end user.
Based on the device type, biopsy devices market is segmented into the following:
• Core biopsy devices
• o Core biopsy needles
• o Core biopsy guns
• Needle-based biopsy devices
• Vacuum-assisted biopsy devices
• o Needles
• o Guns
• Aspiration biopsy needles
• Others
Based on the application, biopsy devices market is segmented into the following:
• Gastrointestinal biopsy
• Lung
• Liver
• Breast biopsy
• Gynaecological
• kidney
• Others
To view TOC of this report is available upon request @
[URL]https://www.precisionbusinessinsights.com/market-reports/global-biopsy-devices-market/#ulp-14mlyhjMGhVjZqa3[/URL]
Biopsy devices market is growing at a significant CAGR due to increase in the prevalence of cancer around the globe. Technological advancements of biopsy devices and increase in the demand for biopsy devices in disease screening for early treatment propel the biopsy devices market
Need more information about this report @
[URL]https://www.precisionbusinessinsights.com/market-reports/global-biopsy-devices-market/#ulp-c654SbFYO64MsOhu[/URL]
Geographically, biopsy devices market is segmented into Europe, North America, Asia Pacific, Latin America, and Middle East and Africa. The growth of North America in biopsy devices market is attributed to increase in R&D activities, technological advancements of biopsy devices, increase in the prevalence of cancer disease (As per National Cancer Institute, in 2016, about 1,685, 210 new cancer cases were diagnosed in the U.S. and approximately 595,690 people will die from cancer), and availability of skilled professionals expected to fuel the biopsy devices market in the region. .
Some of the players in biopsy devices market are Becton, Dickinson and Company (U.S.), Argon Medical Devices (U.S.), Cardinal Health, Inc. (U.S.), Boston Scientific Corporation (U.S.), Medtronic plc (Ireland), B. Braun Melsungen AG (Germany), Olympus Corporation (Japan), Hologic, Inc. (U.S.), SmartTarget Ltd. (U.K.), MDxHealth (Belgium), and Intact Medical Corporation (U.S.) to name a few.
Get access to full summary @
[URL]https://www.precisionbusinessinsights.com/market-reports/global-biopsy-devices-market[/URL]
Contact to Precision Business Insights,
Kemp House,
152 – 160 City Road,
London EC1V 2NX
Email: sales@precisionbusinessinsights.com
Toll Free (US): +1-866-598-1553
Website @ https://www.precisionbusinessinsights.com